that drug is in PhIIa or b trials. it can fail big time. it's too early to claim victory. what's VRTX thinking?? doesn't someone scan or approve their presentations?? does anyone have brains at VRTX who makes decisions??? damn, before long, the stock will be under $5 and they'll be ruining their own clinical trials.